Halozyme Therapeutics IncNASDAQ:HALO
- LAST PRICE33.8900
- TODAY'S CHANGE (%)0.3300 (0.9833%)
- Bid / Lots32.9200/ 2
- Ask / Lots34.6900/ 20
- Open / Previous Close33.2000 / 33.5600
- Day Range
- 52 Week Range
- Volume895,074
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HALO |
|---|---|---|
| 09:32 ET | 32012 | 33.41 |
| 09:33 ET | 6070 | 34.065 |
| 09:35 ET | 1131 | 34.2 |
| 09:37 ET | 2223 | 33.99 |
| 09:39 ET | 1300 | 33.93 |
| 09:42 ET | 3807 | 33.56 |
| 09:44 ET | 900 | 33.55 |
| 09:46 ET | 752 | 33.8 |
| 09:48 ET | 2537 | 33.98 |
| 09:50 ET | 2564 | 33.78 |
| 09:53 ET | 778 | 33.69 |
| 09:55 ET | 1578 | 33.73 |
| 09:57 ET | 1300 | 33.77 |
| 10:00 ET | 1270 | 34.05 |
| 10:02 ET | 1331 | 33.68 |
| 10:04 ET | 200 | 33.585 |
| 10:06 ET | 2165 | 33.71 |
| 10:08 ET | 843 | 33.75 |
| 10:09 ET | 700 | 33.68 |
| 10:11 ET | 600 | 33.605 |
| 10:13 ET | 400 | 33.45 |
| 10:15 ET | 2182 | 33.46 |
| 10:18 ET | 1300 | 33.6 |
| 10:20 ET | 5384 | 33.62 |
| 10:22 ET | 4936 | 33.595 |
| 10:24 ET | 432 | 33.8 |
| 10:26 ET | 7133 | 34.01 |
| 10:27 ET | 1880 | 34.06 |
| 10:29 ET | 5255 | 34.02 |
| 10:31 ET | 2450 | 34.11 |
| 10:33 ET | 6300 | 34.29 |
| 10:36 ET | 6938 | 34.41 |
| 10:38 ET | 5001 | 34.39 |
| 10:40 ET | 2754 | 34.32 |
| 10:42 ET | 12400 | 34.25 |
| 10:44 ET | 2072 | 34.15 |
| 10:45 ET | 700 | 34.1 |
| 10:47 ET | 1600 | 34.27 |
| 10:49 ET | 1843 | 34.46 |
| 10:51 ET | 9517 | 34.54 |
| 10:54 ET | 2871 | 34.4 |
| 10:56 ET | 1030 | 34.505 |
| 10:58 ET | 1652 | 34.35 |
| 11:00 ET | 1200 | 34.5 |
| 11:02 ET | 2296 | 34.301 |
| 11:03 ET | 973 | 34.18 |
| 11:05 ET | 954 | 34.37 |
| 11:07 ET | 600 | 34.4388 |
| 11:09 ET | 2019 | 34.39 |
| 11:12 ET | 1179 | 34.33 |
| 11:14 ET | 600 | 34.3 |
| 11:16 ET | 2914 | 34.3 |
| 11:18 ET | 3048 | 34.43 |
| 11:20 ET | 964 | 34.43 |
| 11:21 ET | 2209 | 34.445 |
| 11:23 ET | 1137 | 34.445 |
| 11:25 ET | 1201 | 34.3 |
| 11:27 ET | 3030 | 34.38 |
| 11:30 ET | 700 | 34.36 |
| 11:32 ET | 3904 | 34.2 |
| 11:34 ET | 1400 | 34.29 |
| 11:36 ET | 2800 | 34.25 |
| 11:38 ET | 1940 | 34.15 |
| 11:39 ET | 2058 | 33.93 |
| 11:41 ET | 946 | 34 |
| 11:43 ET | 400 | 34.05 |
| 11:45 ET | 400 | 34.08 |
| 11:48 ET | 6937 | 33.87 |
| 11:50 ET | 6750 | 33.97 |
| 11:52 ET | 1600 | 34.03 |
| 11:54 ET | 906 | 33.98 |
| 11:56 ET | 1300 | 33.95 |
| 11:57 ET | 1230 | 34.085 |
| 11:59 ET | 263 | 34.06 |
| 12:01 ET | 600 | 34.08 |
| 12:03 ET | 1405 | 33.98 |
| 12:06 ET | 2017 | 34.085 |
| 12:08 ET | 1400 | 34.05 |
| 12:10 ET | 600 | 34.07 |
| 12:12 ET | 710 | 34.09 |
| 12:14 ET | 822 | 33.98 |
| 12:15 ET | 600 | 33.89 |
| 12:17 ET | 3700 | 33.87 |
| 12:19 ET | 1673 | 33.8903 |
| 12:21 ET | 1037 | 33.84 |
| 12:24 ET | 202 | 33.91 |
| 12:26 ET | 1611 | 33.99 |
| 12:28 ET | 308 | 33.98 |
| 12:32 ET | 403 | 34 |
| 12:33 ET | 326 | 34.05 |
| 12:35 ET | 2000 | 34.03 |
| 12:37 ET | 1200 | 33.89 |
| 12:39 ET | 1391 | 34 |
| 12:42 ET | 367 | 34.07 |
| 12:44 ET | 500 | 34.13 |
| 12:46 ET | 1524 | 34.21 |
| 12:48 ET | 790 | 34.13 |
| 12:50 ET | 700 | 34.1 |
| 12:51 ET | 1485 | 34.06 |
| 12:53 ET | 100 | 34.06 |
| 12:55 ET | 536 | 33.94 |
| 12:57 ET | 900 | 34.02 |
| 01:00 ET | 700 | 34.08 |
| 01:02 ET | 967 | 34.16 |
| 01:04 ET | 1100 | 34.09 |
| 01:08 ET | 500 | 34.05 |
| 01:09 ET | 400 | 34.08 |
| 01:11 ET | 1200 | 34.165 |
| 01:13 ET | 100 | 34.15 |
| 01:15 ET | 1593 | 34.12 |
| 01:18 ET | 312 | 34.11 |
| 01:20 ET | 400 | 33.99 |
| 01:22 ET | 380 | 33.9 |
| 01:24 ET | 1220 | 33.91 |
| 01:26 ET | 799 | 33.84 |
| 01:27 ET | 2620 | 33.87 |
| 01:29 ET | 500 | 33.99 |
| 01:31 ET | 1216 | 34.05 |
| 01:33 ET | 1017 | 34.11 |
| 01:36 ET | 500 | 34.035 |
| 01:38 ET | 1800 | 33.99 |
| 01:40 ET | 361 | 34.085 |
| 01:42 ET | 903 | 34.15 |
| 01:44 ET | 906 | 34.12 |
| 01:45 ET | 1417 | 34.07 |
| 01:47 ET | 300 | 34.01 |
| 01:49 ET | 1650 | 34.02 |
| 01:51 ET | 1300 | 34.02 |
| 01:54 ET | 200 | 34.05 |
| 01:56 ET | 300 | 34.02 |
| 01:58 ET | 235 | 34.015 |
| 02:00 ET | 300 | 34 |
| 02:02 ET | 100 | 34 |
| 02:03 ET | 967 | 34.01 |
| 02:05 ET | 900 | 34.065 |
| 02:07 ET | 4399 | 34.03 |
| 02:09 ET | 200 | 33.98 |
| 02:12 ET | 320 | 34.02 |
| 02:14 ET | 1000 | 34.04 |
| 02:16 ET | 1400 | 34.15 |
| 02:18 ET | 200 | 34.09 |
| 02:20 ET | 3221 | 34.081 |
| 02:21 ET | 1965 | 34.14 |
| 02:23 ET | 1209 | 34.09 |
| 02:25 ET | 616 | 34.12 |
| 02:27 ET | 400 | 34.05 |
| 02:30 ET | 200 | 33.985 |
| 02:32 ET | 100 | 34 |
| 02:36 ET | 600 | 33.96 |
| 02:38 ET | 1008 | 33.97 |
| 02:41 ET | 2173 | 34.055 |
| 02:43 ET | 1170 | 34.09 |
| 02:45 ET | 200 | 34.05 |
| 02:48 ET | 1653 | 34.055 |
| 02:50 ET | 1514 | 34.08 |
| 02:52 ET | 100 | 34.06 |
| 02:54 ET | 553 | 33.99 |
| 02:56 ET | 384 | 33.96 |
| 02:57 ET | 600 | 33.85 |
| 02:59 ET | 5546 | 33.89 |
| 03:01 ET | 1549 | 33.93 |
| 03:03 ET | 1925 | 33.955 |
| 03:06 ET | 1100 | 33.9 |
| 03:08 ET | 2851 | 33.82 |
| 03:10 ET | 2491 | 33.83 |
| 03:12 ET | 3649 | 33.804 |
| 03:14 ET | 927 | 33.9 |
| 03:15 ET | 574 | 33.91 |
| 03:17 ET | 4022 | 34.065 |
| 03:19 ET | 13351 | 34.24 |
| 03:21 ET | 14780 | 34.07 |
| 03:24 ET | 1748 | 34.08 |
| 03:26 ET | 1503 | 34.065 |
| 03:28 ET | 1715 | 34 |
| 03:30 ET | 2316 | 34.01 |
| 03:32 ET | 2004 | 34.04 |
| 03:33 ET | 4209 | 34.09 |
| 03:35 ET | 3165 | 34.09 |
| 03:37 ET | 2000 | 34.09 |
| 03:39 ET | 3315 | 34.135 |
| 03:42 ET | 2400 | 34.23 |
| 03:44 ET | 2924 | 34.3 |
| 03:46 ET | 3825 | 34.18 |
| 03:48 ET | 4268 | 34.185 |
| 03:50 ET | 1797 | 34.185 |
| 03:51 ET | 10947 | 34 |
| 03:53 ET | 12231 | 34.005 |
| 03:55 ET | 7631 | 34.01 |
| 03:57 ET | 18026 | 34.03 |
| 04:00 ET | 206694 | 33.89 |
Jan 10, 2022
Halozyme Therapeutics Issues Guidance for 2022; Shares Fall Pre-Bell
BRIEF-Halozyme Therapeutics Sees FY Non-GAAP Earnings Per Share $2.05 To $2.20
HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK
Jan 4, 2022
Halozyme to Present Virtually at the 40th Annual J.P. Morgan Health Care Conference
Dec 29, 2021
BRIEF-Halozyme Therapeutics And Its Unit Halozyme Inc Entered Into A Credit Agreement
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Halozyme Therapeutics Inc | 4.8B | 12.2x | --- |
Ultragenyx Pharmaceutical Inc | 4.6B | -12.7x | --- |
Denali Therapeutics Inc | 4.0B | 868.7x | --- |
Arrowhead Pharmaceuticals Inc | 5.3B | -37.5x | --- |
Zai Lab Ltd | 4.6B | 0.0x | --- |
Vir Biotechnology Inc | 4.4B | -39.5x | --- |
Company Information
Halozyme Therapeutics, Inc. is a biopharma technology platform company. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds. The Company's lead enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. The Company's approved product and its collaborators’ approved products and product candidates are based on rHuPH20, a patented recombinant human hyaluronidase enzyme. The Company's lead product, Hylenex recombinant, is a formulation of rHuPH20 that facilitates subcutaneous fluid administration for achieving hydration, to increase the dispersion and absorption of other injected drugs and, in subcutaneous urography, to improve resorption of radiopaque agents. Its pipeline products include Herceptin SC, HYQVIA, DARZALEX and others.
Contact Information
- Headquarters
- 11388 Sorrento Valley RdSAN DIEGO, CA, United States 92121-1345
- Phone
- 858-794-8889
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Connie Matsui
- President, Chief Executive Officer, Director
- Helen Torley
- Chief Financial Officer, Senior Vice President
- Elaine Sun
- Senior Vice President, Chief Technical Officer
- Michael LaBarre
- Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
- Mark Snyder
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.8B |
|---|---|
Revenue (TTM) | $463.0M |
Shares Outstanding | 140.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.34 |
EPS | $2.79 |
Book Value | $1.12 |
P/E Ratio | 12.2x |
Price/Sales (TTM) | 10.3 |
Price/Cash Flow (TTM) | 11.6x |
Operating Margin | 59.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
